Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Transdermal Drug Delivery dealmaking

2.1. Introduction
2.2. Transdermal Drug Delivery partnering over the years
2.3. Most active Transdermal Drug Delivery dealmakers
2.4. Transdermal Drug Delivery partnering by deal type
2.5. Transdermal Drug Delivery partnering by therapy area
2.6. Deal terms for Transdermal Drug Delivery partnering
2.6.1 Transdermal Drug Delivery partnering headline values
2.6.2 Transdermal Drug Delivery deal upfront payments7
2.6.3 Transdermal Drug Delivery deal milestone payments
2.6.4 Transdermal Drug Delivery royalty rates

Chapter 3 – Leading Transdermal Drug Delivery deals

3.1. Introduction
3.2. Top Transdermal Drug Delivery deals by value

Chapter 4 – Most active Transdermal Drug Delivery dealmakers

4.1. Introduction
4.2. Most active Transdermal Drug Delivery dealmakers
4.3. Most active Transdermal Drug Delivery partnering company profiles

Chapter 5 – Transdermal Drug Delivery contracts dealmaking directory

5.1. Introduction
5.2. Transdermal Drug Delivery contracts dealmaking directory

Chapter 6 – Transdermal Drug Delivery dealmaking by technology type

Chapter 7 – Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 – Transdermal Drug Delivery deals by company A-Z

Appendix 2 – Transdermal Drug Delivery deals by stage of development

Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation

Appendix 3 – Transdermal Drug Delivery deals by deal type

Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty

Appendix 4 – Transdermal Drug Delivery deals by therapy area

Appendix 5 –Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Transdermal Drug Delivery partnering since 2014
Figure 2: Active Transdermal Drug Delivery dealmaking activity– 2014 to 2019
Figure 3: Transdermal Drug Delivery partnering by deal type since 2014
Figure 4: Transdermal Drug Delivery partnering by disease type since 2014
Figure 5: Transdermal Drug Delivery deals with a headline value
Figure 6: Transdermal Drug Delivery deals with an upfront value
Figure 7: Transdermal Drug Delivery deals with a milestone value
Figure 8: Transdermal Drug Delivery deals with a royalty rate value
Figure 9: Top Transdermal Drug Delivery deals by value since 2014
Figure 10: Most active Transdermal Drug Delivery dealmakers 2014 to 2019
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events